A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive, lethal malignancy that invades adjacent vasculatures and spreads to distant sites before clinical detection. Although invasion into the peripancreatic vasculature is one of the hallmarks of PDAC, paradoxically, PDAC tumors also exhibit hypovascularity. How PDAC tumors become hypovascular is poorly understood. We describe an organotypic PDAC-on-a-chip culture model that emulates vascular invasion and tumor-blood vessel interactions to better understand PDAC-vascular interactions. The model features a 3D matrix containing juxtaposed PDAC and perfusable endothelial lumens. PDAC cells invaded through intervening matrix, into vessel lumen, and ablated the endothelial cells, leaving behind tumor-filled luminal structures. Endothelial ablation was also observed in in vivo PDAC models. We also identified the activin-ALK7 pathway as a mediator of endothelial ablation by PDAC. This tumor-on-a-chip model provides an important in vitro platform for investigating the process of PDAC-driven endothelial ablation and may provide a mechanism for tumor hypovascularity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In another study, a biomimetic 3D organotypic model unveiled a mechanism by which pancreatic cancer cells induce endothelial ablation, resulting in tumor-driven endothelial cell death and hypoxia (Nguyen et al., 2019).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Nguyen et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The study identified the activin-ALK7 signaling pathway as a key mediator of this endothelial ablation, suggesting a potential therapeutic strategy for pancreatic cancer by targeting this pathway.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Nguyen et al., 2019
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Several studies have used CoC models to study and understand the effects of these cues on intravasation (Figure 3D-G).”
From Cancer-on-chip models for metastasis: importance of the tumor microenvironment (2024) · cites this paper as [66]
In the citing paper
“Application of a chemotactic gradient of fetal bovine serum (FBS) around the blood vessel triggered the invasion of pancreatic cells, and the wrapping around the blood vessel prior to intravasation.”
From Cancer-on-chip models for metastasis: importance of the tumor microenvironment (2024) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Self-citationInman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,634
Steeg, P. S. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.25 · Cited by 1,363 · cited 1×
“INTRODUCTION Although the diagnosis and treatment of cancer in its earliest stages has substantially improved outcomes in many tumors, survival rates in patients with tumors that have spread to distant sites remain dismal (1).”
Crossing the endothelial barrier during metastasis
Reymond, N., d'Água, B. B., & Ridley, A. J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3628 · Cited by 922
In vitro microvessels for the study of angiogenesis and thrombosis
Zheng, Y., Chen, J., Craven, M., Choi, N. W., Totorica, S., Diaz-Santana, A., Kermani, P., Hempstead, B., Fischbach-Teschl, C., López, J. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201240109 · Cited by 894
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function
Zervantonakis, I. K., Hughes-Alford, S. K., Charest, J. L., Condeelis, J. S., Gertler, F. B., & Kamm, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210182109 · Cited by 872 · cited 1×
“…the interactions between tumor cells with twodimensional (2D) planar or 3D vessel like structures have demonstrated the value of juxtaposing tumor cells with the vascular compartment, especially in the context of investigating extravasation and intrava sation properties ( 14 , 15 , 19 – 21 ).”
Padua, D., & Massagué, J. (2009) · Cell Research · doi:10.1038/cr.2008.316 · Cited by 809
Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation
Jeon, J. S., Bersini, S., Gilardi, M., Dubini, G., Charest, J. L., Moretti, M., & Kamm, R. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417115112 · Cited by 723
Cited by
Items 101–180 of 180
Microphysiological systems as models for immunologically ‘cold’ tumors
Gaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1389012 · Cited by 14
Endothelial cells metabolically regulate breast cancer invasion toward a microvessel
Tan, M. L., Jenkins-Johnston, N., Huang, S., Schutrum, B. E., Vadhin, S., Adhikari, A., Williams, R. M., Zipfel, W. R., Lammerding, J., Varner, J. D., et al. (2023) · APL Bioengineering · doi:10.1063/5.0171109 · Cited by 15
Kolarzyk, A. M., Kwon, Y., Oh, E., Lee, K., Cho, S.-Y., Cano, I., Lu, R., Kwak, T. J., Lee, J., Wong, G., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02384-w · Cited by 14
“However, some other studies suggested that ALK7 might be pro-tumorigenic and pro-metastatic by showing that ALK7 promoted tumor invasion, proliferation, and relapse [11–14].”
Self-citationRecent advances in micro-physiological systems for investigating tumor metastasis and organotropism
Yoon, H., del Río, J. S., Cho, S. W., & Park, T. (2024) · Lab on a Chip · doi:10.1039/d3lc01033c · Cited by 13
Advances in 3D Vascularized Tumor-on-a-Chip Technology
Jung, S., Jo, H., Hyung, S., & Jeon, N. L. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-04039-9_9 · Cited by 13
Lu, R., Lee, B. J., & Lee, E. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c01005 · Cited by 12
Self-citationLiao, Y., Chai, D., Wang, Q., Wang, X., Yong, Q., Cheng, Z., Zhang, C., Zhang, D., Liu, B., Liu, R., et al. (2025) · Materials Horizons · doi:10.1039/d4mh01174k · Cited by 14
Chen, Q., Ren, S., Cui, S., Huang, J., Wang, D., Li, B., He, Q., & Lang, R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1122811 · Cited by 13
“As a hypovascular tumor (26), pancreatic cancer also has limited response to immune checkpoint blockade or chimeric antigen receptor T (27).”
BackgroundGoluba, K., Parfejevs, V., Rostoka, E., Jēkabsons, K., Blāķe, I., Neimane, A., Ule, A. A., Rimša, R., Vangravs, R., Pčolkins, A., et al. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101262 · Cited by 14
“Various PDAC-on-the-chip approaches have been proposed exploring tumour cell cross-talk with stromal components [34 – 37] and vascular endothelium [38].”
BackgroundAksoy, S. A., Earl, J., Grahovac, J., Karakaş, D., Lencioni, G., Sığırlı, S., & Bijlsma, M. F. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.12.003 · Cited by 12
A tumor-microvessel on-a-chip reveals a mechanism for cancer cell cluster intravasation
Ikeda, Y., Kondō, M., Suehiro, J., Oshima, H., Kok, S. Y., Takahashi, K., Pauty, J., Wang, D., Sakurai, H., Watabe, T., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112517 · Cited by 11
“In vivo studies have reported invadopodium formation and vessel co-option in various tumor types, 20,22,23,30–32 yet their specific roles in metastasis remain ambiguous.”
InfluentialMatrix stiffness shapes transcriptional profiles and drug responses of pancreatic cancer cells
Peerani, E., Candido, J. B., Maniati, E., Tomas-Bort, E., Sharma, S., Clegg, J., Kocher, H. M., Wang, J., Curvello, R., & Loessner, D. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.12.020 · Cited by 13
Collagen-Based Biomimetic Systems to Study the Biophysical Tumour Microenvironment
Cambi, A., & Ventre, M. (2022) · Cancers · doi:10.3390/cancers14235939 · Cited by 12
Rimal, R., Desai, P., Bonnin-Marquez, A., Sieg, K., Marquardt, Y., & Singh, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-01513-x · Cited by 12
Parihar, P., Sunildutt, N., Rahim, C. S. A., Samantasinghar, A., Lim, J., & Choi, K. H. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202300410 · Cited by 10
Zhao, Z., Lu, Y., Wang, H., Gu, X., Zhu, L., Guo, H., & Li, N. (2021) · Current Molecular Medicine · doi:10.2174/1566524021666210614144337 · Cited by 10
Role of Lymphatic Endothelium in Vascular Escape of Engineered Human Breast Microtumors
Seibel, A. J., Kelly, O. M., Dance, Y. W., Nelson, C. M., & Tien, J. (2022) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-022-00745-9 · Cited by 10
Engrailed‐1 Promotes Pancreatic Cancer Metastasis
Xu, J., Roe, J., Lee, E., Tonelli, C., Ji, K. Y., Younis, O. W., Somervile, T. D. D., Yao, M. A., Milazzo, J. P., Tiriac, H., et al. (2023) · Advanced Science · doi:10.1002/advs.202308537 · Cited by 10
“Organotypic tumor-on-a-chip assay Detailed protocols to micro-fabricate tumor-blood vessel is described previously (28).”
MethodSelf-citationXu, H., Cheng, C., & Le, W. (2022) · Electrophoresis · doi:10.1002/elps.202100360 · Cited by 10
Zhang, K., Du, Z., Yuan, T., Huang, J., Zhao, X., & Mi, S. (2022) · Biomicrofluidics · doi:10.1063/5.0090027 · Cited by 11
Biomaterials meet organ-on-chips – a perspective on tumor modeling
Monteiro, C. F., Deus, I. A., Custódio, C. A., & Mano, J. F. (2024) · International Materials Reviews · doi:10.1177/09506608241303436 · Cited by 10
“351 In another study, a micro fl ui-dic chip was designed with four adjacent channels separated by pillar structures for the co-culture of breast tumor cells in collagen with an endothelial cell network formed in fi brin hydrogel.”
Advancements in Microfluidic Organ-on-a-chip for Oral Medicine
Fan, S., Ge, Y., Li, B., Liu, P., & Liu, X. (2025) · International Dental Journal · doi:10.1016/j.identj.2025.100925 · Cited by 11
“52-55 ToC for cancers such as lung cancer, 56 breast cancer, 57 and pancreatic cancer 58 has been developed.”
Mayo, L. N., & Kutys, M. L. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00173.2022 · Cited by 9
Meivita, M. P., Lee, D., Naikar, J. S., Go, S., Teoh, W. C., Tan, Y. S., Bajalović, N., & Loke, D. K. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010106 · Cited by 9
“This arises from the propensity of pancreatic tumors to spread to adjacent structures and blood vessels in the early stage [13,14].”
BackgroundLonghini, A. L. F., Fernández-Maestre, I., Kennedy, M. C., Wereski, M. G., Mowla, S., Xiao, W., Lowe, S. W., Levine, R. L., & Gardner, R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1374943 · Cited by 11
“Although it was not statically signi fi cant, we also observed a decrease in the percentage of endothelial cells (Figure 7A), which was expected since PDAC is known to be a poorly vascularized tumor, which has been reported to be due to blood vessels being destroyed by cancer cell in fi ltration (77).”
BackgroundSong, S., Li, B., Carvalho, M. R., Wang, H., Mao, D., Wei, J., Chen, W., Weng, Z.-H., Chen, Y., Deng, C., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108276 · Cited by 11
Mejia, I., Bodapati, S., Chen, K. T., & Díaz, B. (2020) · Biomedicines · doi:10.3390/biomedicines8100401 · Cited by 9
“The hypovascularity observed in the rest of the tumor may be explained in part by the fact that PDAC cells induce apoptosis of the endothelial cells that line the lumen of vessels [129].”
BackgroundEngineering approaches to investigate the roles of lymphatics vessels in rheumatoid arthritis
Kraus, S., & Lee, E. (2022) · Microcirculation · doi:10.1111/micc.12769 · Cited by 8
Self-citationNelson, S. R., & Walsh, N. (2020) · Cancers · doi:10.3390/cancers12051233 · Cited by 9
Jouybar, M., Mikula, A. M., Zuidmeer, N., Konijn, T., de Jonge, A. V., Roest, H. P., Mutis, T., van der Laan, L. J. W., Mebius, R. E., den Toonder, J. M. J., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101544 · Cited by 9
“Various types of templates have been used in this method including PDMS rods and needles [32,40,41].”
Lymphatic Tissue and Organ Engineering for In Vitro Modeling and In Vivo Regeneration
Kolarzyk, A. M., Wong, G., & Lee, E. (2022) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041169 · Cited by 8
“Especially, the blood or LVs-on-a-chip systems are evolving from physiological perspectives of those vessels toward more complex mechanisms of tumor metastasis and immunotherapy through the blood and LVs (Nguyen et al. 2019; Kwak and Lee 2020b,c; Liu et al. 2021); interactions with stromal cells and immune cells (Chun…”
BackgroundSelf-citationResearch Progress in the Field of Tumor Model Construction Using Bioprinting: A Review
Yu, J., Zhang, Y., Ran, R., Kong, Z., Zhao, D., Zhao, W., Yang, Y., Gao, L., & Zhang, Z. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s460387 · Cited by 6
Sgarminato, V., Licciardello, M., Ciardelli, G., & Tonda‐Turo, C. (2024) · International Journal of Bioprinting · doi:10.36922/ijb.1975 · Cited by 6
Triplicate Dynamic Cell Culture Platform for Enhanced Reproducibility in Anti-Cancer Drug Testing
Lu, Y., Lin, C.-M., & Huang, J. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c02142 · Cited by 5
Lin, Y.-Y., Esswein, P. J., Ramirez, L. P., Warren, E. C., Nicenboim, J., & Gerecht, S. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01712-9 · Cited by 6
Casanova, A., Alimohammadzadeh, E., McCormirk, S., Thomas, Y. R. J., den Dulk, R., Baldi, A., Fernández‐Sánchez, C., Ghaemmaghami, A. M., & Mailley, P. (2026) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2026.118981 · Cited by 6
Inactivation of Notch4 Attenuated Pancreatic Tumorigenesis in Mice
Saeki, K., Qiu, W., Friedman, R. A., Pan, S. S., Lu, J., Ichimiya, S., Chio, I. I. C., Shawber, C. J., Kitajewski, J., Hu, J., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0106 · Cited by 5
Wang, C., Liu, S., Li, C., Wang, Z., Ming, R., & Huang, L. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c15125 · Cited by 5
MEMS in Twenty-First-Century Healthcare
Noushin, T., Parvez, M. S., Biswas, P., Bhuiyan, M. E. H., Rumon, M. A. A., & Tabassum, S. (2025) · Springer tracts in electrical and electronics engineering · doi:10.1007/978-981-96-4659-3_3 · Cited by 9
Ortiz-Collazos, S., Sousa-Batista, A. J., & Balbino, T. A. (2024) · Biochemical Engineering Journal · doi:10.1016/j.bej.2024.109475 · Cited by 6
Handschin, C., Shalhoub, H., Mazet, A., Guyon, C., Dusserre, N., Boutet-Robinet, E. A., Oliveira, H., & Guillermet‐Guibert, J. (2025) · Biofabrication · doi:10.1088/1758-5090/adb51c · Cited by 5
Bioengineering 3D Pancreatic Cancer Models with Fibrotic Stroma for In Vitro Cancer Modeling
Lan, X., Chen, K., & Wei, X. (2025) · Micromachines · doi:10.3390/mi16101140 · Cited by 4
“A dual-channel microfluidic chip was developed featuring two parallel hollow cylindrical channels embedded within a collagen matrix for studying PDAC–vascular interactions (Figure 3C) [77].”
Tumour-on-Chip Models for the Study of Ovarian Cancer: Current Challenges and Future Prospects
Lim, S. Y., Aboelnasr, L. S., & El-Bahrawy, M. A. (2025) · Cancers · doi:10.3390/cancers17193239 · Cited by 4
“More complex designs are also possible, and Nguyen et al. [44] utilised this design to model pancreatic ductal adenocarcinoma (PDAC) interactions with blood vessels.”
The Microenvironment of Solid Tumors: Components and Current Challenges of Tumor-on-a-Chip Models
Souza, I. D. F., Vieira, J. P. D. J., Bonifácio, E., Freitas, B. A. D. A., & Torres, L. A. G. (2024) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2024.0088 · Cited by 5
“74 This model was important for studying vascular invasion and tumor – blood vessel interactions to better understand PDAC-vascular interactions.”
Decoding physical principles of cell migration under controlled environment using microfluidics
Suh, Y. J., Li, A. T., Pandey, M., Nordmann, C. S., Huang, Y., & Wu, M. (2024) · Biophysics Reviews · doi:10.1063/5.0199161 · Cited by 5
Shao, Z., Zhan, B., Du, Y., Wang, X., Liu, S., Zhang, X., & Chen, X. (2025) · Industrial Crops and Products · doi:10.1016/j.indcrop.2025.121283 · Cited by 5
Vascularized Organoid-on-Chip Platforms: Expanding the Bioengineering Frontiers with Microfluidics
Konwarh, R. (2025) · Biomaterials Connect · doi:10.69709/biomatc.2025.155652 · Cited by 4
Tumbic, J., Ferrarese, E., Martinez, R., Ackleson, T., Delgado, D., & Highley, C. B. (2025) · Biofabrication · doi:10.1088/1758-5090/adfe97 · Cited by 4
“Various types of cancer have also been shown to ablate nearby vascularized channels [78–80] and this could be recapitulated in the system shown here.”
Brimhall, K. C., Kuhfeldt, K., Kotton, D. N., & Jones, M. R. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1581205 · Cited by 6
Jouybar, M., van der Kallen, S., Moradi, H., Zuo, P., Stassen, O. M. J. A., & den Toonder, J. M. J. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101926 · Cited by 6
Zhang, S., He, Y., Chang, H., Tian, Y., Wang, X., Feng, Z., Qi, W., & Liu, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-40948-y · Cited by 2
“Extensive studies have reported pancreatic adenocarcinoma-driven endothelial ablation 13 .”
Digitally Fabricated and Naturally Augmented In Vitro Tissues
Campos, D. F. D., & Laporte, L. D. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001253 · Cited by 2
Microfluidic Models of the Tumor Microenvironment
Chang, C.-S., Holter, J. C., & Song, J. W. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166013-00252 · Cited by 2
Zhang, C., Hao, W., Wang, X., Guo, H., He, L., Jiao, Y., Wang, Y., Zheng, X., Li, Z., Han, Q., et al. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5583 · Cited by 1
“…AcVR1c has been shown to suppress cell proliferation and induce apoptosis through regulation of the SMAd2/3 pathway (23,38‑40). conversely, AcVR1c has been implicated in oncogenic roles in certain cancers, such as pancreatic ductal adenocarcinoma (41), prolactinoma (24) and retinoblastoma (42).”
Hu, X., Zhang, Y., Lu, Y., Zheng, F., Zhang, K., Jiang, M., Chen, C., Wei, Z., & Wang, J. (2026) · Small · doi:10.1002/smll.73850 · Cited by 2
Self-citationDing, Y., Zhao, P., Yan, J., Li, Y., Wang, Z., Lu, Y., Zhang, Y., Chen, H., Zhang, W., Luan, X., et al. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10366-7 · Cited by 1
“In a biomimetic PDAC-on-chip system, a PDAC-containing conduit channel was placed adjacent to a perfusable endothelialized lumen within a collagen matrix [217].”
Protein hydrogels: structure, characteristics, and applications
Hromić‐Jahjefendić, A., Golzardi, M., & Uversky, V. N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21809-5.00002-8 · Cited by 2
Chen, S., Yue, S., Ba, W., & Jin, F. (2025) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2025.125942 · Cited by 1
Molecular and morphologic study of pancreatic cancer evolution
Noë, M. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/3
Modeling metastasis: engineering approaches to study the metastatic cascade
Pruitt, H. C., & Gerecht, S. (2020) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/abc34f
“This model was used to show that the mechanism behind this phenomenon in pancreatic cancer was ALK7 signaling [ 73].”
Challenges and Perspectives on the Use of Pericytes in Tissue Engineering
Hsu, G. C., Lu, A. Z., Bertassoni, L. E., & França, C. M. (2022) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-022-00039-2
Mimicking Multicellular Features of the Tumor Microenvironment
Curvello, R., & Loessner, D. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166013-00141
Human organs-on-a-chip for cancer modeling
Hegde, M., Girisa, S., & Harsha, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00005-x
Organs-on-a-chip in drug development
Mohandas, S., Kumaran, K., & Ramkumar, K. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00001-2
Lialios, P., Kim, Y., Trewhella, I., Myakala, K., Hughes, E. P., Wang, X. X., Levi, M., & Alimperti, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.19.654627
Self-citationA breast Duct-on-Chip model for emulating invasive ductal carcinoma and testing therapiesPreprint
Jouybar, M., & den Toonder, J. M. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.24.655087
Tumor-on-a-Chip: From Biomimetic Tumor-Immune Microenvironments to Therapeutic Insights
Çetin, Y. (2025) · Biochemistry · doi:10.5772/intechopen.1012047
Chen, Q., Ren, S., Cui, S., He, Q., & Lang, R. (2023) · Research Square · doi:10.21203/rs.3.rs-2505664/v1
Tan, M. L. (2023) · eCommons (Cornell University) · doi:10.7298/sk6k-2p95
Development of Novel Microfluidic-based Pancreatic-Cancer-on-a-Chip Models
Geyer, M. (2023) · Cited by 1
Etude de l'effet du microenvironnement sur le développement de tumeur pancréatique
Coffy, S. (2024) · theses.fr (ABES) · doi:10.70675/bd0a1100zdd28z43d2zb675zdbbcc6dab559
Développement de cancer sur puce : application au cancer du pancréas
Godier, C. (2024) · theses.fr (ABES) · doi:10.70675/a4e7b29ez87b0z4647za5a1z9c43ddd1a8f0
Hypoxia-on-chip : from technological developments to biological applications
Bouquerel, C. (2023) · theses.fr (ABES) · doi:10.70675/d7d58b5dzd927z4235z8c54z8dbb6fd4757e · Cited by 1
New insights in tumor-on-a-chip models for studying cancer drug resistance
Wang, Y., Shi, L., Li, J., Zhang, X., Ren, J., Jia, Q., Lv, L., Yang, L., Zhang, Z., Yang, J., et al. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156562
Immune-driven stromal inflammation in pancreatic cancer within a microfluidic platform
Viso, M. E., Rajkumar, K., Bianchi, A., Suthar, B., Kumar, N., Oliver, D., Collins, M. A., Datta, J., & Agarwal, A. (2026) · Biofabrication · doi:10.1088/1758-5090/ae7b09
Son, D. W., Lim, Y., Yu, C. S., Cha, M. J., Lee, E. J., Kim, H., Lee, H., Hong, S.-M., Park, H., & Chang, S. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03052-2
“Collective invasion has been reported as a crucial mechanism of cancer invasion in breast cancer [45, 46] and pancreatic cancer [18, 47, 48].”
Self-citationHahne, J. (2026) · Directory of Open access Books (OAPEN Foundation)
Richardson, L. C., Cano, I., Kolarzyk, A. M., & Lee, E. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.10.013
Self-citation
Metadata
- Authors
- Nguyen, D.-H. T., Lee, E., Alimperti, S., Norgard, R. J., Wong, A., Lee, J. J.-K., Eyckmans, J., Stanger, B. Z., & Chen, C. S.
- Affiliations
- University of Pennsylvania (US)
- Boston University (US)
- Harvard University (US)
- Corresponding author
- Nguyen, Duc-Huy T.
- Lee, Esak
- Chen, Christopher S.
- ORCID
- Venue
- Science Advances
- Published
- 2019-08-02
- Volume
- 5
- Issue
- 8
- Pages
- eaav6789-eaav6789
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC6713506
- OpenAlex
- W2970097127
- Cited by
- 172
- References
- 40
- Citations by year
- 2026: 8 · 2025: 30 · 2024: 28 · 2023: 26 · 2022: 25 · 2021: 27 · 2020: 26 · 2019: 2
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- OpenBU (Boston University) (submittedVersion, cc-by-nc)
- Funders
- National Institutes of Health (EB00262, UH3EB017103, UC4DK104196)
- National Center for Advancing Translational Sciences (TL1TR001410)
- Lymphatic Education and Research Network (LE&RN Postdoctoral Fellowship)
- Harvard Ludwig Center
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- pancreatic ductal adenocarcinoma, tumor vascular invasion, tumor angiogenesis
- MeSH terms
- Adenocarcinoma, Animals, Cell Line, Humans, Neoplasm Invasiveness, Pancreatic Neoplasms, Signal Transduction, Carcinoma, Pancreatic Ductal, Activin Receptors, Type I, Biomimetics, Endothelial Cells, Cell Line, Tumor, Mice, Human Umbilical Vein Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.